CRVO: CervoMed Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 72.41
Enterprise Value ($M) 63.41
Book Value ($M) 39.20
Book Value / Share 4.50
Price / Book 1.85
NCAV ($M) 39.20
NCAV / Share 4.50
Price / NCAV 1.85

Profitability (mra)
Return on Invested Capital (ROIC) -0.42
Return on Assets (ROA) -2.04
Return on Equity (ROE) -3.05

Liquidity (mrq)
Quick Ratio 11.11
Current Ratio 11.11

Balance Sheet (mrq) ($M)
Current Assets 43.08
Assets 43.08
Liabilities 3.88
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 9.74
Operating Income -18.23
Net Income -16.29
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -16.53
Cash from Investing -28.66
Cash from Financing 46.40

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Ra Capital Management, L.p. 9.90 10.99
01-13 13G/A AWM Investment Company, Inc. 4.70 -52.57

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-09 87,115 323,078 26.96
2025-04-08 208,152 575,103 36.19
2025-04-07 123,700 434,761 28.45
2025-04-04 395,014 1,215,365 32.50

(click for more detail)

Similar Companies
CRBP – Corbus Pharmaceuticals Holdings, Inc. CRDF – Cardiff Oncology, Inc.
CRIS – Curis, Inc. CSBR – Champions Oncology, Inc.
CSCI – COSCIENS Biopharma Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.